Drugs / AMT2003
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00405873 | Mar 2007 → Mar 2010 | hepatocellular carcinoma | Auron Healthcare GmbH | Terminated | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT00405561 | Oct 2006 → Jan 2010 | colorectal carcinoma | Auron Healthcare GmbH | Terminated | No outcome recorded |
| Phase 2/3 | NCT00332280 | May 2006 → Jan 2010 | digestive system cancer, female reproductive system neoplasm, prostate cancer | Auron Healthcare GmbH | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMT2003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00405873 ↗ |